Literature DB >> 23301833

Older men with dementia are at greater risk than women of serious events after initiating antipsychotic therapy.

Paula A Rochon1, Andrea Gruneir, Sudeep S Gill, Wei Wu, Hadas D Fischer, Susan E Bronskill, Sharon-Lise T Normand, Peter C Austin, Dallas P Seitz, Chaim M Bell, Longdi Fu, Lorraine Lipscombe, Geoffrey M Anderson, Jerry H Gurwitz.   

Abstract

OBJECTIVES: To understand how drug therapy differently affects older women and men.
DESIGN: Population-based, retrospective cohort study.
SETTING: Ontario, Canada. PARTICIPANTS: Twenty-one thousand five hundred twenty-six older adults (13,760 women, 7,766 men) with dementia newly started on oral atypical antipsychotic therapy between April 1, 2007, and March 1, 2010. MEASUREMENTS: Numbers and rates of serious events. Serious events were defined as a hospital admission or death within 30 days of treatment initiation. Unadjusted and adjusted odds ratios of women and men were compared in the full cohort and in strata based on setting of care, age, Charlson Comorbidity Index (CCI), and antipsychotic dose.
RESULTS: Of 21,526 older adults with a median age of 84, 1,889 (8.8%) had a serious event (1,044 women, 7.6%; 845 men, 10.9%). Of these, 363 women (2.6%) and 355 men (4.6%) died. Men were more likely than women to be hospitalized or die during the 30-day follow-up period (adjusted odds ratio = 1.47, 95% confidence interval = 1.33-1.62) and consistently more likely to experience a serious event in each stratum. A gradient of risk according to drug dose was found for the development of a serious event in women and men.
CONCLUSION: The risk of developing a serious event shortly after the initiation of antipsychotic therapy was high in women and men with dementia but was consistently higher in older men. This pattern remained the same in strata based on setting of care, age, CCI, and antipsychotic dose.
© 2012, Copyright the Authors Journal compilation © 2012, The American Geriatrics Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23301833     DOI: 10.1111/jgs.12061

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  8 in total

Review 1.  Impact of Age and Sex on QT Prolongation in Patients Receiving Psychotropics.

Authors:  Simon W Rabkin
Journal:  Can J Psychiatry       Date:  2015-05       Impact factor: 4.356

2.  Sex and gender considerations in Canadian clinical practice guidelines: a systematic review.

Authors:  Cara Tannenbaum; Barbara Clow; Margaret Haworth-Brockman; Patrice Voss
Journal:  CMAJ Open       Date:  2017-02-10

3.  A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.

Authors:  Daniela C Moga; Heidi Taipale; Anna-Maija Tolppanen; Antti Tanskanen; Jari Tiihonen; Sirpa Hartikainen; Qishan Wu; Gregory A Jicha; Danijela Gnjidic
Journal:  Drugs Aging       Date:  2017-01       Impact factor: 3.923

4.  Factors Related to Rejection of Care and Behaviors Directed towards Others: A Longitudinal Study in Nursing Home Residents with Dementia.

Authors:  Francisca Galindo-Garre; Ladislav Volicer; Jenny T van der Steen
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-04-10

5.  Detailed analysis of the impact of age on the QT interval.

Authors:  Simon W Rabkin; Xin-Bo Justin Cheng; Darby Js Thompson
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

6.  Public reporting of antipsychotic prescribing in nursing homes: population-based interrupted time series analyses.

Authors:  Noah M Ivers; Monica Taljaard; Vasily Giannakeas; Catherine Reis; Evelyn Williams; Susan Bronskill
Journal:  BMJ Qual Saf       Date:  2018-07-30       Impact factor: 7.035

7.  Comparison of prescribing practices for older adults treated by female versus male physicians: A retrospective cohort study.

Authors:  Paula A Rochon; Andrea Gruneir; Chaim M Bell; Rachel Savage; Sudeep S Gill; Wei Wu; Vasily Giannakeas; Nathan M Stall; Dallas P Seitz; Sharon-Lise Normand; Lynn Zhu; Nathan Herrmann; Lisa McCarthy; Colin Faulkner; Jerry H Gurwitz; Peter C Austin; Susan E Bronskill
Journal:  PLoS One       Date:  2018-10-22       Impact factor: 3.240

8.  Use of Drugs With Risk of Heart Rate-Related Problems is Common in Norwegian Dementia Patients Treated With Acetylcholinesterase Inhibitors: A Prevalence Study Based on the Norwegian Prescription Database.

Authors:  Anne Sverdrup Efjestad; Hege Ihle-Hansen; Vidar Hjellvik; Knut Engedal; Hege Salvesen Blix
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.